UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Gold nanoparticles as a contrast agent for in vivo tumor imaging with photoacoustic tomography

Nanotechnology, 2009-09, Vol.20 (39), p.395102-395102

2009

Link zum Volltext

Verfügbarkeit prüfen

Navigation surgery for intraoperative sentinel lymph node detection using Indocyanine green (ICG) fluorescence real-time imaging in breast cancer

Breast cancer research and treatment, 2015-09, Vol.153 (2), p.337-344

2015

Link zum Volltext

Verfügbarkeit prüfen

Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing

ESMO open, 2024-04, Vol.9 (4), p.102385-102385, Article 102385

2024

Link zum Volltext

Verfügbarkeit prüfen

P223 Image-guided sentinel lymph node detection using near-infrared fluorescence in breast cancer

Breast (Edinburgh), 2015-03, Vol.24, p.S102-S102

2015

Link zum Volltext

Verfügbarkeit prüfen

P008 S-1 in combination with CPT-11 plus trastuzumab for pretreated HER2+ metastatic breast cancer

Breast (Edinburgh), 2015-03, Vol.24, p.S28-S28

2015

Link zum Volltext

Verfügbarkeit prüfen

P192 Study of neoadjuvant therapy with FEC followed by weekly nab-paclitaxel for breast cancer

Breast (Edinburgh), 2015-03, Vol.24, p.S90-S90

2015

Link zum Volltext

Verfügbarkeit prüfen

335 FOXP3 Expression in Tumor Cells Associated with the Prognosis in Breast Cancer Patients

European journal of cancer (1990), 2012-03, Vol.48, p.S140-S140

2012

Link zum Volltext

Verfügbarkeit prüfen

478 Radiation-induced Pulmonary Injury After Radiotherapy for Early Breast Conserving Therapy

European journal of cancer (1990), 2012-03, Vol.48, p.S186-S186

2012

Link zum Volltext

Verfügbarkeit prüfen

75 The Potential of Targeting Nanoparticle for Breast Cancer Diagnosis

European journal of cancer (1990), 2012-03, Vol.48, p.S62-S62

2012

Link zum Volltext

Verfügbarkeit prüfen

421P Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer

Annals of oncology, 2023-10, Vol.34, p.S359-S360

2023

Link zum Volltext

Verfügbarkeit prüfen

228P Fulvestrant with additional palbociclib in advanced or metastatic hormone receptor-positive HER2-negative breast cancer after progression to fulvestrant monotherapy: JBCRG- M07 (FUTURE trial)

Annals of oncology, 2022-09, Vol.33, p.S642

2022

Link zum Volltext

Verfügbarkeit prüfen

P326 Immunologic and clinical effects of personalized selection of peptide vaccines in patients with refractory breast cancer

Breast (Edinburgh), 2011, Vol.20, p.S79-S79

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-05-09: Prognostic factors for therapeutic personalized peptide vaccines in patients with metastatic recurrent breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P3-P3-05-09

2018

Link zum Volltext

Verfügbarkeit prüfen

63: Novel Gold Speckled Silica Nanoparticles as Mediators of in Vivo Tumor Imaging and Photothermal Ablation

The Journal of surgical research, 2009, Vol.151 (2), p.199-200

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-06-06: Comparison of the immunological and clinical effect of personalized peptide vaccination for patients with breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-06-06

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-08-16: Local immunologic environment related with tumor infiltrating lymphocytes (TIL) and PD-1/PD-L1 expression in early stage breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P5-P5-08-16

2016

Link zum Volltext

Verfügbarkeit prüfen

635 The usefulness of screening FDG-PET for breast cancer

European journal of cancer supplements, 2010, Vol.8 (3), p.243-243

2010

Link zum Volltext

Verfügbarkeit prüfen

Heat-shock pre-treatment reduces liver injury and aids liver recovery after partial hepatectomy in mice

Anticancer research, 2013-07, Vol.33 (7), p.2887-2894

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-11-04: Serum IgG response against prostate-related antigen revealed by personalized peptide vaccination in patients with metastatic recurrent breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P2-P2-11-04

2016

Link zum Volltext

Verfügbarkeit prüfen

97 Novel gold speckled silica nanoparticle (GSS) as madiators of tumour imaging and photothermal ablation (University of Florida and Kurume University, Cancer Nanotechnology Study Group)

European journal of cancer supplements, 2010, Vol.8 (3), p.86-86

2010

Link zum Volltext

Verfügbarkeit prüfen

494 Phase II study of S-1 in combination with irinotecan (CPT-11) for patients with advanced/recurrent breast cancer (KSCOG-BC01)

European journal of cancer supplements, 2010, Vol.8 (3), p.204-204

2010

Link zum Volltext

Verfügbarkeit prüfen

What is cancer nanotechnology?

Methods in molecular biology (Clifton, N.J.), 2010-01, Vol.624, p.1

2010

Link zum Volltext

Verfügbarkeit prüfen

Multimodal nanoparticulate bioimaging contrast agents

Methods in molecular biology (Clifton, N.J.), 2010-01, Vol.624, p.67

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-01-05: Personalized peptide vaccines in combination with conventional chemo- or endocrine therapy for metastatic breast cancer: A single-arm phase II study

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P5-P5-01-05

2013

Link zum Volltext

Verfügbarkeit prüfen

A multicenter phase II study of S-1 combined with irinotecan (CPT-11) for patients with advanced/recurrent breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e11528-e11528

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Englisch
(109)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Physical Sciences
(33)
Physics
(30)
Physics, Applied
(25)
Life Sciences & Biomedicine
(22)
Technology
(22)
Superconductivity
(20)
Exact Sciences And Technology
(19)
Animals
(16)
Humans
(16)
Applied Sciences
(13)
Superconductors
(13)
Engineering
(11)
Female
(11)
Male
(11)
Electrical Engineering. Electrical Power Engineering
(10)
Engineering, Electrical & Electronic
(10)
Hematology, Oncology And Palliative Medicine
(10)
Middle Aged
(9)
Superconducting Coils
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gold nanoparticles as a contrast agent for in vivo tumor imaging with photoacoustic tomography

Navigation surgery for intraoperative sentinel lymph node detection using Indocyanine green (ICG) fluorescence real-time imaging in breast cancer

Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing

P223 Image-guided sentinel lymph node detection using near-infrared fluorescence in breast cancer

P008 S-1 in combination with CPT-11 plus trastuzumab for pretreated HER2+ metastatic breast cancer

P192 Study of neoadjuvant therapy with FEC followed by weekly nab-paclitaxel for breast cancer

335 FOXP3 Expression in Tumor Cells Associated with the Prognosis in Breast Cancer Patients

478 Radiation-induced Pulmonary Injury After Radiotherapy for Early Breast Conserving Therapy

75 The Potential of Targeting Nanoparticle for Breast Cancer Diagnosis

421P Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer

228P Fulvestrant with additional palbociclib in advanced or metastatic hormone receptor-positive HER2-negative breast cancer after progression to fulvestrant monotherapy: JBCRG- M07 (FUTURE trial)

P326 Immunologic and clinical effects of personalized selection of peptide vaccines in patients with refractory breast cancer

Abstract P3-05-09: Prognostic factors for therapeutic personalized peptide vaccines in patients with metastatic recurrent breast cancer

63: Novel Gold Speckled Silica Nanoparticles as Mediators of in Vivo Tumor Imaging and Photothermal Ablation

Abstract P4-06-06: Comparison of the immunological and clinical effect of personalized peptide vaccination for patients with breast cancer

Abstract P5-08-16: Local immunologic environment related with tumor infiltrating lymphocytes (TIL) and PD-1/PD-L1 expression in early stage breast cancer

635 The usefulness of screening FDG-PET for breast cancer

Heat-shock pre-treatment reduces liver injury and aids liver recovery after partial hepatectomy in mice

Abstract P2-11-04: Serum IgG response against prostate-related antigen revealed by personalized peptide vaccination in patients with metastatic recurrent breast cancer

97 Novel gold speckled silica nanoparticle (GSS) as madiators of tumour imaging and photothermal ablation (University of Florida and Kurume University, Cancer Nanotechnology Study Group)

494 Phase II study of S-1 in combination with irinotecan (CPT-11) for patients with advanced/recurrent breast cancer (KSCOG-BC01)

What is cancer nanotechnology?

Multimodal nanoparticulate bioimaging contrast agents

Abstract P5-01-05: Personalized peptide vaccines in combination with conventional chemo- or endocrine therapy for metastatic breast cancer: A single-arm phase II study

A multicenter phase II study of S-1 combined with irinotecan (CPT-11) for patients with advanced/recurrent breast cancer

Suchergebnisse filtern